2m 2m 2m 2m 2m 2m 2m
Aurinia Pharma (AUPH)
NASDAQ
$16.92+$0.02 (+0.09%)
Price as of Oct 22, 2026 7:30 PM EDT- $2.2BMarket Cap
- 42.98%1-Year Change
- BiotechnologyIndustry
Aurinia Pharma (AUPH)
$16.92+$0.02 (+0.09%)
AUPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.90 | ||
Change | +$0.16 (+0.96%) | ||
Open | $16.73 | ||
High | $17.01 | ||
Low | $16.63 | ||
Previous Close | $16.74 | ||
Volume | 783,237 | ||
30-Day Average Volume | 804,258 | ||
1-Week Change | 1.75% | ||
1-Month Change | 1.75% | ||
1-Year Change | 42.98% | ||
3-Year Change | 125.33% | ||
5-Year Change | -23.49% | ||
Fundamentals | |||
Shares Outstanding | 133.1M | ||
Total Assets | $792.3M | ||
Market Cap | $2.2B | ||
Enterprise Value | $2.1B | ||
Period: QTR TTM FY | |||
Revenue | $79.4M | ||
Net Income | $37.4M | ||
Free Cash Flow | $52.6M | ||
EBIT | $48.8M | ||
EBITDA | $53.6M | ||
Net Working Capital | $441.4M | ||
EPS | $0.28 | ||
Enterprise Value/EBITDA | 39 | ||
Enterprise Value/Revenue | 26 | ||
P/B | 4 | ||
P/E | 60 | ||
PEG | 5 | ||
Price/Free Cash Flow | 43 | ||
Price/Operating Cash Flow | 43 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue